Article
The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.
Tuberculosis (Edinburgh, Scotland) - 1 May 2017
Graustein Andrew D, Horne David J, Fong Jerry J, Schwarz Flavio, Mefford Heather C, Peterson Glenna J, Wells Richard D, Musvosvi Munyaradzi, Shey Muki, Hanekom Willem A, Hatherill Mark, Scriba Thomas J, Thuong Nguyen Thuy Thuong, Mai Nguyen Thi Hoang, Caws Maxine, Bang Nguyen Duc, Dunstan Sarah J, Thwaites Guy E, Varki Ajit, Angata Takashi, Hawn Thomas R
Abstract excerpt
Humans exposed to Mycobacterium tuberculosis (Mtb) have variable susceptibility to tuberculosis (TB) and its outcomes. Siglec-5 and Siglec-14 are members of the sialic-acid binding lectin family that regulate immune responses to pathogens through inhibitory (Siglec-5) and activating (Siglec-14) domains. The SIGLEC14 coding sequence is deleted in a high proportion of individuals, placing a SIGLEC5-like gene under...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
